{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:02:46Z","timestamp":1788930166757,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Scientific research project of Shanghai Science and Technology Commission","award":["18401900900"],"award-info":[{"award-number":["18401900900"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10067-024-07282-y","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T09:12:02Z","timestamp":1735204322000},"page":"601-613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and validation of predictive factors influencing rheumatoid arthritis associated with interstitial lung disease"],"prefix":"10.1007","volume":"44","author":[{"given":"Wenyi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8887-9510","authenticated-orcid":false,"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"issue":"10055","key":"7282_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038","journal-title":"Lancet"},{"key":"7282_CR2","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS et al (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:18001","journal-title":"Nat Rev Dis Primers"},{"issue":"13","key":"7282_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360\u20131372","journal-title":"JAMA"},{"issue":"12","key":"7282_CR4","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1001\/jama.2022.0786","volume":"327","author":"MH Smith","year":"2022","unstructured":"Smith MH, Berman JR (2022) What is rheumatoid arthritis? JAMA 327(12):1194","journal-title":"JAMA"},{"issue":"1","key":"7282_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","volume":"73","author":"M Dougados","year":"2014","unstructured":"Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH et al (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73(1):62\u201368","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7282_CR6","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 20(4):102776","journal-title":"Autoimmun Rev"},{"issue":"8","key":"7282_CR7","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1093\/rheumatology\/keaa860","volume":"60","author":"NMT Roodenrijs","year":"2021","unstructured":"Roodenrijs NMT, van der Goes MC, Welsing PMJ, Tekstra J, Lafeber F, Jacobs JWG et al (2021) Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology (Oxford) 60(8):3778\u20133788","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"7282_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","volume":"36","author":"J Rojas-Serrano","year":"2017","unstructured":"Rojas-Serrano J, Herrera-Bringas D, Perez-Roman DI, Perez-Dorame R, Mateos-Toledo H, Mejia M (2017) Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Clin Rheumatol 36(7):1493\u20131500","journal-title":"Clin Rheumatol"},{"issue":"10","key":"7282_CR9","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/art.40574","volume":"70","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V (2018) The lung in rheumatoid arthritis: focus on interstitial lung disease. Arthritis Rheumatol 70(10):1544\u20131554","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"7282_CR10","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00296-017-3781-7","volume":"37","author":"D Kim","year":"2017","unstructured":"Kim D, Cho SK, Choi CB, Choe JY, Chung WT, Hong SJ et al (2017) Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis. Rheumatol Int 37(10):1735\u20131745","journal-title":"Rheumatol Int"},{"issue":"10","key":"7282_CR11","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Lokke A, Bendstrup E et al (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76(10):1700\u20131706","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"7282_CR12","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH et al (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62(6):1583\u20131591","journal-title":"Arthritis Rheum"},{"issue":"18","key":"7282_CR13","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718\u20131727","journal-title":"N Engl J Med"},{"key":"7282_CR14","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2147\/DDDT.S204730","volume":"13","author":"Y Huang","year":"2019","unstructured":"Huang Y, Lin W, Chen Z, Wang Y, Huang Y, Tu S (2019) Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon? Drug Des Devel Ther 13:2111\u20132125","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"7282_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S2213-2600(21)00017-5","volume":"9","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Ryerson CJ, Putman R, Oldham J, Salisbury M, Sverzellati N et al (2021) Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. Lancet Respir Med 9(9):1065\u20131076","journal-title":"Lancet Respir Med"},{"issue":"9","key":"7282_CR16","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588","journal-title":"Ann Rheum Dis"},{"issue":"suppl_6","key":"7282_CR17","first-page":"vi5","volume":"51","author":"J Kay","year":"2015","unstructured":"Kay J, Upchurch KS (2015) ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology 51(suppl_6):vi5\u2013vi9","journal-title":"Rheumatology"},{"issue":"2 Pt 1","key":"7282_CR18","first-page":"646","volume":"161","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161(2 Pt 1):646\u201364","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"7282_CR19","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J et al (2009) Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68(6):954\u2013960","journal-title":"Ann Rheum Dis"},{"key":"7282_CR20","unstructured":"Department of Medical Affairs, State Administration of Traditional Chinese Medicine\u00a0(2010) Clinical pathways of traditional Chinese medicine for 95 diseases in 22 specialties (Bound edition). China Traditional Chinese Medicine Press,\u00a0Beijing"},{"issue":"5","key":"7282_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3899\/jrheum.200863","volume":"48","author":"VL Kronzer","year":"2021","unstructured":"Kronzer VL, Huang W, Dellaripa PF, Huang S, Feathers V, Lu B et al (2021) Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease. J Rheumatol 48(5):656\u2013663","journal-title":"J Rheumatol"},{"issue":"8","key":"7282_CR22","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00296-023-05313-6","volume":"43","author":"GM Koduri","year":"2023","unstructured":"Koduri GM, Podlasek A, Pattapola S, Zhang J, Laila D, Nandagudi A et al (2023) Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis. Rheumatol Int 43(8):1515\u20131523","journal-title":"Rheumatol Int"},{"issue":"38","key":"7282_CR23","doi-asserted-by":"publisher","first-page":"e17088","DOI":"10.1097\/MD.0000000000017088","volume":"98","author":"F Salaffi","year":"2019","unstructured":"Salaffi F, Carotti M, Di Carlo M, Tardella M, Giovagnoni A (2019) High-resolution computed tomography of the lung in patients with rheumatoid arthritis: prevalence of interstitial lung disease involvement and determinants of abnormalities. Medicine (Baltimore) 98(38):e17088","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"7282_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.reuma.2019.05.007","volume":"17","author":"F Paulin","year":"2021","unstructured":"Paulin F, Doyle TJ, Mercado JF, Fassola L, Fernandez M, Caro F et al (2021) Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis. Reumatol Clin (Engl Ed) 17(4):207\u2013211","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"3","key":"7282_CR25","first-page":"344","volume":"56","author":"JA Zamora-Legoff","year":"2017","unstructured":"Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL (2017) Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology (Oxford) 56(3):344\u2013350","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"7282_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J et al (2011) Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 183(3):372\u2013378","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"7282_CR27","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1513\/AnnalsATS.202102-115OC","volume":"18","author":"N Jeganathan","year":"2021","unstructured":"Jeganathan N, Nguyen E, Sathananthan M (2021) Rheumatoid arthritis and associated interstitial lung disease: mortality rates and trends. Ann Am Thorac Soc 18(12):1970\u20131977","journal-title":"Ann Am Thorac Soc"},{"key":"7282_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.rmed.2017.03.027","volume":"126","author":"ZX Yunt","year":"2017","unstructured":"Yunt ZX, Chung JH, Hobbs S, Fernandez-Perez ER, Olson AL, Huie TJ et al (2017) High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: relationship to survival. Respir Med 126:100\u2013104","journal-title":"Respir Med"},{"issue":"10","key":"7282_CR29","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/ard.2007.075192","volume":"67","author":"D Makrygiannakis","year":"2008","unstructured":"Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A et al (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67(10):1488\u20131492","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7282_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-023-03140-5","volume":"25","author":"Y Shao","year":"2023","unstructured":"Shao Y, Zhang H, Shi Q, Wang Y, Liang Q (2023) Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease. Arthritis Res Ther 25(1):159","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"7282_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","volume":"36","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li H, Wu N, Dong X, Zheng Y (2017) Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 36(4):817\u2013823","journal-title":"Clin Rheumatol"},{"issue":"9","key":"7282_CR32","first-page":"53","volume":"29","author":"XQ Ge","year":"2021","unstructured":"Ge XQ, Zhang JS, Zhang ZC (2021) Influencing factors and construction of risk prediction nomogram model of rheumatoid arthritis patients complicated with interstitial lung disease. Pract J Card Cereb Pneumal Vasc Dis 29(9):53\u20138","journal-title":"Pract J Card Cereb Pneumal Vasc Dis"},{"issue":"4","key":"7282_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.reuma.2019.06.001","volume":"17","author":"N Mena-Vazquez","year":"2021","unstructured":"Mena-Vazquez N, Perez Albaladejo L, Manrique-Arija S, Romero Barco CM, Gomez Cano C, UrenaGarnica I et al (2021) Analysis of clinical-analytical characteristics in patients with rheumatoid arthritis and interstitial lung disease: case-control study. Reumatol Clin (Engl Ed) 17(4):197\u2013202","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"2","key":"7282_CR34","doi-asserted-by":"publisher","first-page":"e001278","DOI":"10.1136\/rmdopen-2020-001278","volume":"6","author":"V Joshua","year":"2020","unstructured":"Joshua V, Hensvold AH, Reynisdottir G, Hansson M, Cornillet M, Nogueira L et al (2020) Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis. RMD Open 6(2):e001278","journal-title":"RMD Open"},{"issue":"9","key":"7282_CR35","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","volume":"34","author":"JF Restrepo","year":"2015","unstructured":"Restrepo JF, del Rincon I, Battafarano DF, Haas RW, Doria M, Escalante A (2015) Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis. Clin Rheumatol 34(9):1529\u20131536","journal-title":"Clin Rheumatol"},{"issue":"8","key":"7282_CR36","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J et al (2010) Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 49(8):1483\u20131489","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"7282_CR37","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.3390\/ijms24076800","volume":"24","author":"N Mena-Vazquez","year":"2023","unstructured":"Mena-Vazquez N, Godoy-Navarrete FJ, Lisbona-Montanez JM, Redondo-Rodriguez R, Manrique-Arija S, Rioja J et al (2023) Inflammatory biomarkers in the diagnosis and prognosis of rheumatoid arthritis-associated interstitial lung disease. Int J Mol Sci 24(7):6800","journal-title":"Int J Mol Sci"},{"issue":"5","key":"7282_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","volume":"43","author":"C Roubille","year":"2014","unstructured":"Roubille C, Haraoui B (2014) Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum 43(5):613\u2013626","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"7282_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","volume":"66","author":"R Conway","year":"2014","unstructured":"Conway R, Low C, Coughlan RJ, O\u2019Donnell MJ, Carey JJ (2014) Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheumatol 66(4):803\u2013812","journal-title":"Arthritis Rheumatol"},{"key":"7282_CR40","doi-asserted-by":"publisher","unstructured":"Juge PA, Lee JS, Lau J, Kawano-Dourado L, Rojas Serrano J, Sebastiani M, Koduri G, Matteson E, Bonfiglioli K, Sawamura M, Kairalla R, Cavagna L, Bozzalla Cassione E, Manfredi A, Mejia M, Rodr\u00edguez-Henriquez P, Gonz\u00e1lez-P\u00e9rez MI, Falf\u00e1n-Valencia R, Buendia-Rold\u00e1n I, P\u00e9rez-Rubio G, Ebstein E, Gazal S, Borie R, Ottaviani S, Kannengiesser C, Wallaert B, Uzunhan Y, Nunes H, Valeyre D, Saidenberg-Kermanac\u2019h N, Boissier MC, Wemeau-Stervinou L, Flipo RM, Marchand-Adam S, Richette P, Allanore Y, Dromer C, Truchetet ME, Richez C, Schaeverbeke T, Liot\u00e9 H, Thabut G, Deane KD, Solomon JJ, Doyle T, Ryu JH, Rosas I, Holers VM, Boileau C, Debray MP, Porcher R, Schwartz DA, Vassallo R, Crestani B, Dieud\u00e9 P (2021) Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J 57(2):2000337. https:\/\/doi.org\/10.1183\/13993003.00337-2020","DOI":"10.1183\/13993003.00337-2020"},{"issue":"11","key":"7282_CR41","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/resp.13365","volume":"23","author":"Y Yamano","year":"2018","unstructured":"Yamano Y, Taniguchi H, Kondoh Y, Ando M, Kataoka K, Furukawa T et al (2018) Multidimensional improvement in connective tissue disease-associated interstitial lung disease: two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus. Respirology 23(11):1041\u20131048","journal-title":"Respirology"},{"issue":"14","key":"7282_CR42","first-page":"4687","volume":"25","author":"P Shu","year":"2021","unstructured":"Shu P, Shao SQ, Cai XN, Zhou DM, Ma H, Lu L et al (2021) Iguratimod attenuates general disease activity and improves lung function in rheumatoid arthritis-associated interstitial lung disease patients. Eur Rev Med Pharmacol Sci 25(14):4687\u20134692","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07282-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07282-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07282-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:32:04Z","timestamp":1738045924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07282-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7282"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07282-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"This study received approval from the Ethics Committee of Longhua Hospital, affiliated with Shanghai University of Traditional Chinese Medicine (approval numbers 2021LCSY028). And the ethical committee waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LS has received research grants from the Scientific Research Project of Shanghai Science and Technology Commission (no. 18401900900).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}